| Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, in vitro and in silico studies DIA Othman, A Hamdi, SS Tawfik, AA Elgazar, AS Mostafa Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2166037, 2023 | 43 | 2023 |
| New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study MM Al-Sanea, A Hamdi, AAB Mohamed, HW El-Shafey, M Moustafa, ... Journal of enzyme inhibition and medicinal chemistry 38 (1), 2166036, 2023 | 32 | 2023 |
| Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: Molecular modeling studies A Hamdi, HW El-Shafey, DIA Othman, AS El-Azab, NA AlSaif, AM Alaa Bioorganic Chemistry 122, 105710, 2022 | 25 | 2022 |
| Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2, 4-dione derivatives: histone deacetylases inhibitory activity and molecular docking … A Hamdi, WM Elhusseiny, DIA Othman, A Haikal, AH Bakheit, AS El-Azab, ... European Journal of Medicinal Chemistry 244, 114827, 2022 | 23 | 2022 |
| Novel 2-arylthiazolidin-4-one-thiazole hybrids with potent activity against Mycobacterium tuberculosis DIA Othman, A Hamdi, MM Abdel-Aziz, SM Elfeky Bioorganic Chemistry 124, 105809, 2022 | 22 | 2022 |
| Development of new thiazolidine-2, 4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: Design, synthesis, biological investigations, and in … A Hamdi, M Yaseen, WA Ewes, MA Bhat, NI Ziedan, HW El-Shafey, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2231170, 2023 | 19 | 2023 |
| Novel quinazolin-2-yl 1, 2, 3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study NFM El Hamaky, A Hamdi, WA Bayoumi, AA Elgazar, MNA Nasr Bioorganic Chemistry 148, 107437, 2024 | 13 | 2024 |
| Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents MM Al-Sanea, A Hamdi, S Brogi, S S. Tawfik, DIA Othman, M Elshal, ... Journal of enzyme inhibition and medicinal chemistry 38 (1), 2162511, 2023 | 13 | 2023 |
| Anti-inflammatory effect of 3-fluorophenyl pyrimidinylimidazo [2, 1-b] thiazole derivatives as p38α inhibitors MM Al-Sanea, MS Abdel-Maksoud, MF El-Behairy, A Hamdi, HU Rahman, ... Bioorganic Chemistry 139, 106716, 2023 | 13 | 2023 |
| Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors MM Al-Sanea, G Chilingaryan, N Abelyan, M Mamikonyan, H Gasparyan, ... PLoS One 17 (9), e0272065, 2022 | 12 | 2022 |
| Unraveling the nephroprotective potential of papaverine against cisplatin toxicity through mitigating oxidative stress and inflammation: insights from in silico, in vitro, and … SA Abass, AA Elgazar, SS El-Kholy, AI El-Refaiy, RA Nawaya, MA Bhat, ... Molecules 29 (9), 1927, 2024 | 11 | 2024 |
| Acetylene-free synthesis of vinyloxy pyridine and quinoline A Hamdi, AS Mostafa, CN Watat, MY Laurent, KB Ayed, KB Selim, ... Tetrahedron Letters 57 (51), 5825-5829, 2016 | 10 | 2016 |
| Synthesis and in vivo antifibrotic activity of novel leflunomide analogues A Hamdi, E Said, A A Farahat, S AA El-Bialy, M AM Massoud Letters in Drug Design & Discovery 13 (9), 912-920, 2016 | 9 | 2016 |
| Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and in silico study DIA Othman, A Hamdi, WM Elhusseiny, AS El-Azab, AH Bakheit, ... Saudi Pharmaceutical Journal 31 (11), 101803, 2023 | 8 | 2023 |
| Identification of benzothiazoles bearing 1, 3, 4-thiadiazole as antiproliferative hybrids targeting VEGFR-2 and BRAF kinase: design, synthesis, BIO evaluation and in silico study WA Ewes, SS Tawfik, AM Almatary, M Ahmad Bhat, HW El-Shafey, ... Molecules 29 (13), 3186, 2024 | 6 | 2024 |
| S-Alkylated quinazolin-4 (3 H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study SS Tawfik, A Hamdi, AR Ali, AA Elgazar, HW El-Shafey, AS El-Azab, ... RSC advances 14 (36), 26325-26339, 2024 | 5 | 2024 |
| Understanding chemistry and unique NMR characters of novel amide and ester leflunomide analogues MA Henen, A Hamdi, AA Farahat, MAM Massoud Magnetochemistry 3 (4), 41, 2017 | 4 | 2017 |
| Harnessing potential COX-2 engagement for boosting anticancer activity of substituted 2-mercapto-4 (3H)-quinazolinones with promising EGFR/VEGFR-2 inhibitory activities A Hamdi, SS Tawfik, AR Ali, WA Ewes, A Haikal, AS El-Azab, AH Bakheit, ... Bioorganic Chemistry 153, 107951, 2024 | 2 | 2024 |
| 1, 3-Dipolar cycloaddition of vinyloxy quinolines with α-alkoxy carbonyl aldonitrones or cyclic surrogates: A comparative study for an asymmetric access to trans 4-quinolinoxy … A Hamdi, MY Laurent, A Hémon-Ribaud, AS Mostafa, MAM Massoud, ... Tetrahedron 75 (3), 429-440, 2019 | 2 | 2019 |
| Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors MM Al-Sanea, HM Hafez, AAB Mohamed, HW El-Shafey, AA Elgazar, ... Drug Design, Development and Therapy, 5109-5127, 2024 | 1 | 2024 |
ِAbdullah A. ElgazarAssistant Professor of Pharmacognosy, kafrelsheikh Universityยืนยันอีเมลแล้วที่ pharm.kfs.edu.eg
